1.37 USD
▲+0.09+6.64%
盘后 1.30 0.00%
2026-11-20
市值
$141.45M
市盈率
—
EPS
-0.26
股息率
—
52 周区间
0.64 – 1.80
成交量
964.48K
Beta
1.48
目标价
4.11
52W 低 0.6452W 高 1.80
价格走势

公司简介

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engi...